175 related articles for article (PubMed ID: 29674723)
1. STEAP2 Knockdown Reduces the Invasive Potential of Prostate Cancer Cells.
Burnell SEA; Spencer-Harty S; Howarth S; Bodger O; Kynaston H; Morgan C; Doak SH
Sci Rep; 2018 Apr; 8(1):6252. PubMed ID: 29674723
[TBL] [Abstract][Full Text] [Related]
2. A role for STEAP2 in prostate cancer progression.
Whiteland H; Spencer-Harty S; Morgan C; Kynaston H; Thomas DH; Bose P; Fenn N; Lewis P; Jenkins S; Doak SH
Clin Exp Metastasis; 2014 Dec; 31(8):909-20. PubMed ID: 25248617
[TBL] [Abstract][Full Text] [Related]
3. Investigating STEAP2 as a potential therapeutic target for the treatment of aggressive prostate cancer.
Jones LA; Conway GE; Nguyen-Chi A; Burnell S; Jenkins GJ; Conlan RS; Doak SH
Cell Mol Biol (Noisy-le-grand); 2023 Apr; 69(4):179-187. PubMed ID: 37329528
[TBL] [Abstract][Full Text] [Related]
4. Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion.
Tiwari A; Mukherjee B; Hassan MK; Pattanaik N; Jaiswal AM; Dixit M
BMC Cancer; 2019 Apr; 19(1):346. PubMed ID: 30975102
[TBL] [Abstract][Full Text] [Related]
5. A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer.
Seibert JK; Quagliata L; Quintavalle C; Hammond TG; Terracciano L; Odermatt A
Cancer Med; 2015 Nov; 4(11):1717-29. PubMed ID: 26311046
[TBL] [Abstract][Full Text] [Related]
6. TGF-β Effects on Prostate Cancer Cell Migration and Invasion Require FosB.
Barrett CS; Millena AC; Khan SA
Prostate; 2017 Jan; 77(1):72-81. PubMed ID: 27604827
[TBL] [Abstract][Full Text] [Related]
7. The migration and invasion of human prostate cancer cell lines involves CD151 expression.
Ang J; Fang BL; Ashman LK; Frauman AG
Oncol Rep; 2010 Dec; 24(6):1593-7. PubMed ID: 21042756
[TBL] [Abstract][Full Text] [Related]
8. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin Up-Regulates Annexin A10 That Can Inhibit the Proliferation, Migration, and Invasion in Androgen-Independent Human Prostate Cancer Cells.
Miyazawa Y; Sekine Y; Kato H; Furuya Y; Koike H; Suzuki K
Prostate; 2017 Mar; 77(4):337-349. PubMed ID: 27862098
[TBL] [Abstract][Full Text] [Related]
11. Effect of AQP9 Expression in Androgen-Independent Prostate Cancer Cell PC3.
Chen Q; Zhu L; Zheng B; Wang J; Song X; Zheng W; Wang L; Yang D; Wang J
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187384
[TBL] [Abstract][Full Text] [Related]
12. Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion.
Wen YA; Zhou BW; Lv DJ; Shu FP; Song XL; Huang B; Wang C; Zhao SC
Asian J Androl; 2018; 20(2):178-183. PubMed ID: 29271400
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of a novel six-transmembrane protein STEAP2, expressed in normal and malignant prostate.
Porkka KP; Helenius MA; Visakorpi T
Lab Invest; 2002 Nov; 82(11):1573-82. PubMed ID: 12429817
[TBL] [Abstract][Full Text] [Related]
14. Critical role of endogenous heme oxygenase 1 as a tuner of the invasive potential of prostate cancer cells.
Gueron G; De Siervi A; Ferrando M; Salierno M; De Luca P; Elguero B; Meiss R; Navone N; Vazquez ES
Mol Cancer Res; 2009 Nov; 7(11):1745-55. PubMed ID: 19903769
[TBL] [Abstract][Full Text] [Related]
15. Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82.
Dodla P; Bhoopalan V; Khoo SK; Miranti C; Sridhar S
BMC Cancer; 2020 Dec; 20(1):1211. PubMed ID: 33298014
[TBL] [Abstract][Full Text] [Related]
16. Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression.
Shajari N; Davudian S; Kazemi T; Mansoori B; Salehi S; Khaze Shahgoli V; Shanehbandi D; Mohammadi A; Duijf PHG; Baradaran B
Artif Cells Nanomed Biotechnol; 2018 Nov; 46(7):1495-1504. PubMed ID: 28889753
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia regulates ANXA1 expression to support prostate cancer cell invasion and aggressiveness.
Bizzarro V; Belvedere R; Migliaro V; Romano E; Parente L; Petrella A
Cell Adh Migr; 2017 May; 11(3):247-260. PubMed ID: 27834582
[TBL] [Abstract][Full Text] [Related]
18. IgG silencing induces apoptosis and suppresses proliferation, migration and invasion in LNCaP prostate cancer cells.
Xu Y; Chen B; Zheng S; Wen Y; Xu A; Xu K; Li B; Liu C
Cell Mol Biol Lett; 2016; 21():27. PubMed ID: 28536629
[TBL] [Abstract][Full Text] [Related]
19. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast activation protein-alpha knockdown suppresses prostate cancer cell invasion and proliferation.
An J; Hou D; Wang L; Wang L; Yang Y; Wang H
Histol Histopathol; 2022 Jun; 37(6):597-607. PubMed ID: 35129203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
